Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: 16 Week Results of a Phase 3 Randomized, Double-Blind, Placebo Controlled Trial in Patients with Prior Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors - Deodhar, A; Poddubnyy, D; Pacheco-Tena, C (Arthritis Rheumatol, 2018)
et al.